Luspatercept for beta-thalassemia – A new horizon?

Mohammad Ammad Ud Din, Faiz Anwer

Research output: Contribution to journalReview articlepeer-review

Abstract

Several treatment options are being explored to reduce the transfusion burden and improve quality of life for patients with beta-thalassemia. One such prospect is the drug luspatercept, which has recently been approved for use in the USA for the treatment of beta-thalassemia. However, socioeconomic factors may act as a barrier to its widespread use.

Original languageEnglish (US)
Pages (from-to)16-17
Number of pages2
JournalEuropean Oncology and Haematology
Volume16
Issue number1
DOIs
StatePublished - 2020
Externally publishedYes

Keywords

  • Beta-thalassemia
  • Cooley’s anaemia
  • Luspatercept
  • Microcytaemia
  • Thalassemia
  • Thalassemia major

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Luspatercept for beta-thalassemia – A new horizon?'. Together they form a unique fingerprint.

Cite this